Try our Advanced Search for more refined results
- Law360
- Law360 UK
- Law360 Pulse
- Law360 Employment Authority
- Law360 Tax Authority
- Law360 Insurance Authority
- Law360 Real Estate Authority
- Law360 Healthcare Authority
- Law360 Bankruptcy Authority
- Products
- Lexis®
- Law360 In-Depth
- Law360 Podcasts
- Rankings
- Leaderboard Analytics
- Regional Powerhouses
- Law360's MVPs
- Women in Law Report
- Law360 400
- Diversity Snapshot
- Practice Groups of the Year
- Rising Stars
- Titans of the Plaintiffs Bar
- Sections
- Adv. Search & Platform Tools
- About all sections
- Browse all sections
- Banking
- Bankruptcy
- Class Action
- Competition
- Employment
- Energy
- Expert Analysis
- Insurance
- Intellectual Property
- Product Liability
- Securities
- Beta Tools
- Track docs
- Track attorneys
- Track judges
COUNCIL ON RADIONUCLIDES AND RADIOPHARMACEUTICALS, INC. v. AZAR et al
Case Number:
1:18-cv-00633
Court:
Nature of Suit:
Administrative Procedure Act/Review or Appeal of Agency Decision
Judge:
Firms
Government Agencies
-
November 13, 2019
HHS Beats Suit Over Radioactive Drugs In Medicaid Program
A D.C. federal judge on Wednesday tossed a suit challenging the federal government's determination that radiopharmaceutical products are covered outpatient drugs under the Medicaid drug rebate program, saying a trade association didn't show that its members would be harmed by the finding.
-
March 20, 2018
Medicaid Rule Can't Govern Radioactive Drugs, Suit Says
The Council on Radionuclides and Radiopharmaceuticals hit the U.S. Health and Human Services agency and its secretary with a lawsuit in D.C. federal court Monday, asking the court to find radiopharmaceutical products are not covered outpatient drugs under the agency's 2016 final Medicaid rebate program rule.